Erick Gamelin
Corporate Officer/Principal at ACRIVON THERAPEUTICS, INC.
Net worth: 150 470 $ as of 2024-04-29
Profile
Erick Gamelin is currently the Chief Development Officer at Acrivon Therapeutics, Inc. He previously held positions as the Vice President-Oncology at Dynavax Technologies Corp., Vice President at MacroGenics, Inc., and Chief Medical Officer at Step Pharma SAS.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-13 | 17,765 ( 0.06% ) | 150 470 $ | 2024-04-29 |
Erick Gamelin active positions
| Companies | Position | Start |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Corporate Officer/Principal | 2024-01-02 |
Former positions of Erick Gamelin
| Companies | Position | End |
|---|---|---|
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Chief Tech/Sci/R&D Officer | 2020-12-31 |
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 2019-09-30 |
| MACROGENICS, INC. | Corporate Officer/Principal | 2018-02-28 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ACRIVON THERAPEUTICS, INC. | Health Technology |
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| MACROGENICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Erick Gamelin
